intranasal carbetocin

carbetocin · Levo Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for intranasal carbetocin, covering 2021-11-17 to 2021-11-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome [Phase 3]